openPR Logo
Press release

Generic Injectables Market 2022: Global Industry Trends, Future Growth, Regional Overview, Market Share, Size, Revenue, and Forecast Outlook till 2028

08-17-2022 02:44 PM CET | Health & Medicine

Press release from: The Insight Partners

Generic Injectables Market

Generic Injectables Market

The Generic Injectables market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.

The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.74 billion in 2021; it is expected to register a CAGR of 10.5% from 2021 to 2028.

Generic injectables are the bioequivalents of their branded counterparts and are not protected by patents. They are safe and effective as the innovator drugs since they have similar active ingredients, dosages, strength, qualities, form, etc.

Get Sample PDF Copy of Generic Injectables Market at: https://www.theinsightpartners.com/sample/TIPRE00004765/?utm_source=OpenPr&utm_medium=10545

List of Companies operating in this report are:
• Astrazeneca
• Baxter International, Inc.
• Biocon
• Fresenius SE & Co. KGaA
• GlaxoSmithKline Plc
• Hikma Pharmaceuticals
• Johnson & Johnson Services, Inc.
• Lupin, Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Pfizer, Inc

Furthermore, the market is segmented based on type, application, and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Product Type-Based Insights
Based on product type, the generic injectables market is segmented into large molecule injectables and small molecule injectables. In 2021, the large molecule injectables segment accounted for a greater market share. The market position of this segment is credited to a surge in the adoption of biologics in the healthcare sector, and the progress of monoclonal antibody and antibody-drug conjugates (ADCs) into the drug development.

Container Type-Based Insights
Based on container type, the generic injectables market is segmented into vials, premix, prefilled syringes, ampoules, and others. The vials segment is likely to dominate the market in 2021.

Application-Based Insights
The generic injectables market, based on application, has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. The oncology segment is likely to hold the largest share of the market in 2021. An increase in cancer incidences and rise in the launch of drugs is anticipated drives the growth of the oncology market segment.

Have Question? Speak to Analyst at: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004765?utm_source=OpenPr&utm_medium=10545

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Generic Injectables market.

Essential points covered in Generic Injectables market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of Generic Injectables market?
3 What are the key market trends impacting Generic Injectables market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Generic Injectables market?
6 Which are the leading companies contributing to Generic Injectables market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Generic Injectables market in 2028?

Order a Copy of Generic Injectables Market Share, Strategies and Forecasts 2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00004765/?utm_source=OpenPr&utm_medium=10545

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Injectables Market 2022: Global Industry Trends, Future Growth, Regional Overview, Market Share, Size, Revenue, and Forecast Outlook till 2028 here

News-ID: 2707348 • Views:

More Releases from The Insight Partners

Avocado Oil Market Business Prospects and Growth Projections to 2027
Avocado Oil Market Business Prospects and Growth Projections to 2027
Avocado oil are perceived to be one of the healthiest ingredient which can be used in various food products such as bakery & confectionary, beverages, dairy & frozen desserts, and sweet & savory snacks. Avocado oil is gaining high popularity among the consumers due to rising awareness about the health benefits offered by avocado oil. Download sample PDF: https://www.theinsightpartners.com/sample/TIPRE00010900/?utm_source=OpenPR&utm_medium=10822 The avocado oil market, based on nature, is segmented into organic and conventional.
Optical Coating Market Classification, Opportunities, Types and Applications, St …
An optical coating is made of a combination of thin film layers that create interference effects to enhance transmission or reflection properties within an optical system. An optical coating is composed of a blend of thin layers of materials such as metals, rare earth materials, or oxides. The performance of an optical coating is dependent upon the number of layers, the thickness of the individual layers, and the refractive index
Infantile Spasms Therapeutics Market Partnering Deals of Key Players 2024-2031
Infantile Spasms Therapeutics Market Partnering Deals of Key Players 2024-2031
The Infantile Spasms Therapeutics Market size (volume and value) and industry chain structure published by The Insight Partners through its high quality database which is a valuable source of guidance and direction for companies and individual interested in the industry. Major companies with their market volumes and revenues are covered for each of the regions (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America). Download Sample PDF
Sailcloth Market SWOT analysis by Size, Status and Forecast 2030
Sailcloth Market SWOT analysis by Size, Status and Forecast 2030
The latest market research released by The Insight Partners- "Growth Projections on Sailcloth Market - Statistics and Facts" is the one-stop solution for all Sailcloth market-related queries. Sailcloth market size is projected to grow from US$ 133.18 million in 2022 to US$ 171.69 million by 2030; it is anticipated to register a CAGR of 3.2% from 2022 to 2030. This report offers a thorough picture of those challenges to prepare businesses

All 5 Releases


More Releases for Generic

Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
This week a special offer is introduced by Generic Wellness for weight loss treatment with an oral drug called generic Xenical. The drug is an excellent weight loss treatment for all men and women above the age of 12. People who have taken this drug for weight loss have actually experienced the benefits like reduction of unwanted fat in the body. This is possible with generic Xenical because of the
Generic Drugs Market Trends 2025
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drugs Market - Global Competitive Analysis
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by